Clinical Trial Update: Study of Mycobacterium w in Superficial Transitional Cell Carcinoma of Bladder [Phase 2]

View source ↗

Summary

Phase 2 trial update on Mycobacterium w for superficial transitional cell carcinoma of the bladder has completed recruitment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Drugs mentioned

• Mycobacterium w (Mycobacterium w)

Snippet

Sponsor: Cadila Pharnmaceuticals | Conditions: Bladder Cancer | Phase 2 | Status: COMPLETED